Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
Open Access
- 1 June 2016
- journal article
- research article
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 7 (2) , 80-86
Abstract
Objective: To study the effects of losartan and atenolol on glucometabolic parameters in nondiabetic hypertensive patients. Materials and Methods: In a prospective, open-label, parallel group study, nondiabetic patients with mild to moderate hypertension were randomized to either losartan (titrated from 50 to 100 mg/day, n = 20) or atenolol (titrated from 25 mg to 100 mg/day, n = 20) for period of 24 weeks. At baseline, 12 and 24 weeks fasting plasma glucose (FPG), fasting plasma insulin (FPI), homeostasis model assessment for insulin resistance (HOMA-IR) apart from lipid parameters, mean systolic, and diastolic blood pressures levels were determined. Results: At the end of study, losartan significantly (P < 0.05) reduced FPG, FPI, and HOMA-IR compared to atenolol and baseline. While atenolol increased the HOMA-IR levels significantly compared to the baseline. Conclusions: Losartan improved the insulin sensitivity while atenolol worsened it. Losartan is better than atenolol for its effects on the glucose-insulin metabolism.Keywords
This publication has 28 references indexed in Scilit:
- Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on Glucose tolerance and ENdothelial function - a crossover Trial (AGENT)Cardiovascular Diabetology, 2011
- Effects of Telmisartan and Losartan on Insulin Resistance in Hypertensive Patients with Metabolic SyndromeHypertension Research, 2007
- Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factorsJournal of Human Hypertension, 2006
- Antihypertensive Medications and the Risk of Incident Type 2 DiabetesDiabetes Care, 2006
- Antihypertensive medications and blood sugar: Theories and implicationsCanadian Journal of Cardiology, 2006
- Dual Blockade of Angiotensin II with Enalapril and Losartan Reduces Proteinuria in Hypertensive Patients with Type 2 DiabetesEndocrine Journal, 2006
- Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonistsJournal Of Hypertension, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension studyJournal Of Hypertension, 2002
- Diabetes, Hypertension, and Cardiovascular DiseaseHypertension, 2001